市場調査レポート

商品コード

早漏治療の世界市場 2025～2029年

Global Premature Ejaculation Treatment Market 2025-2029

出版日: 2024年12月19日
発行: TechNavio
ページ情報: 英文 201 Pages
納期: 即納可能

カスタマイズ可能

価格

PDF (Single User License)

USD 2,500 368,200円

レポートPDFをご購入者の1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 4,000 589,120円

レポートPDFを同一組織内のすべての方にて共有ご使用頂けるライセンスです。ご利用人数に制限はありません。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は制限なく何回でも可能ではありますが、印刷物のご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=147.28円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

早漏治療市場 2025～2029年

早漏治療市場は2024～2029年に15億2,770万米ドル、予測期間中のCAGRは8.6%で成長すると予測されます。当レポートでは、早漏治療市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、適応外早漏治療薬の高い有効性、早漏治療に対する局所薬物療法の需要増加、早漏を引き起こすリスク要因の増加によって牽引されています。

市場範囲
基準年	2025
終了年	2029
予測期間	2025-2029
成長モメンタム	加速
前年比2025年	8%
CAGR	8.6%
増分額	15億2,770万米ドル

本調査では、早漏治療医薬品におけるナノテクノロジーの出現が、今後数年間の早漏治療市場成長を牽引する主要な理由の一つであると特定しています。また、早漏治療に関する研究開発の増加や、早漏治療用の新しいデバイスの出現は、市場の大きな需要につながります。

企業プロファイル
企業ランキング指数
企業の市場ポジショニング
A. Menarini Industrie Farmaceutiche Riunite Srl
Absorption Pharmaceuticals LLC
Alembic Pharmaceuticals Ltd.
Amneal Pharmaceuticals Inc.
Aytu BioPharma Inc.
Bayer AG
Eli Lilly and Co.
Futura Medical Plc
GlaxoSmithKline Plc
Johnson and Johnson Inc.
LloydsPharmacy
NeuroHealing Pharmaceuticals Inc.
Pfizer Inc.
Plethora Solutions Ltd.
Veru Inc.

第15章付録

図表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits11: Overview on criticality of inputs and factors of differentiation
Exhibits12: Overview on factors of disruption
Exhibits13: Impact of drivers and challenges in 2024 and 2029
Exhibits14: Parent Market
Exhibits15: Data Table on - Parent Market
Exhibits16: Market characteristics analysis
Exhibits17: Value chain analysis
Exhibits18: Offerings of companies included in the market definition
Exhibits19: Market segments
Exhibits20: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits21: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits22: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits23: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Historic Market Size - Data Table on Global Premature Ejaculation Treatment Market 2019 - 2023 ($ million)
Exhibits25: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibits26: Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits28: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits29: Five forces analysis - Comparison between 2024 and 2029
Exhibits30: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits31: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits32: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits33: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits34: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits35: Chart on Market condition - Five forces 2024 and 2029
Exhibits36: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibits37: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibits38: Chart on Comparison by Route of Administration
Exhibits39: Data Table on Comparison by Route of Administration
Exhibits40: Chart on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits41: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits42: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibits43: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibits44: Chart on Topical - Market size and forecast 2024-2029 ($ million)
Exhibits45: Data Table on Topical - Market size and forecast 2024-2029 ($ million)
Exhibits46: Chart on Topical - Year-over-year growth 2024-2029 (%)
Exhibits47: Data Table on Topical - Year-over-year growth 2024-2029 (%)
Exhibits48: Market opportunity by Route of Administration ($ million)
Exhibits49: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits50: Chart on Drug Class - Market share 2024-2029 (%)
Exhibits51: Data Table on Drug Class - Market share 2024-2029 (%)
Exhibits52: Chart on Comparison by Drug Class
Exhibits53: Data Table on Comparison by Drug Class
Exhibits54: Chart on SSRIs - Market size and forecast 2024-2029 ($ million)
Exhibits55: Data Table on SSRIs - Market size and forecast 2024-2029 ($ million)
Exhibits56: Chart on SSRIs - Year-over-year growth 2024-2029 (%)
Exhibits57: Data Table on SSRIs - Year-over-year growth 2024-2029 (%)
Exhibits58: Chart on PDE5 inhibitors - Market size and forecast 2024-2029 ($ million)
Exhibits59: Data Table on PDE5 inhibitors - Market size and forecast 2024-2029 ($ million)
Exhibits60: Chart on PDE5 inhibitors - Year-over-year growth 2024-2029 (%)
Exhibits61: Data Table on PDE5 inhibitors - Year-over-year growth 2024-2029 (%)
Exhibits62: Chart on Amide anesthetics - Market size and forecast 2024-2029 ($ million)
Exhibits63: Data Table on Amide anesthetics - Market size and forecast 2024-2029 ($ million)
Exhibits64: Chart on Amide anesthetics - Year-over-year growth 2024-2029 (%)
Exhibits65: Data Table on Amide anesthetics - Year-over-year growth 2024-2029 (%)
Exhibits66: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits67: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits68: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits69: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits70: Market opportunity by Drug Class ($ million)
Exhibits71: Data Table on Market opportunity by Drug Class ($ million)
Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits73: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits74: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits75: Chart on Geographic comparison
Exhibits76: Data Table on Geographic comparison
Exhibits77: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits78: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits79: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits80: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits81: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits82: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits83: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits84: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits85: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits86: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits87: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits88: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits93: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits94: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits95: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits96: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits97: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits98: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits99: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits100: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits101: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits102: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits103: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits104: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits105: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits106: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits107: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits110: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits111: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits118: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits119: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits122: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits123: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits126: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits127: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
Exhibits130: Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
Exhibits131: Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
Exhibits133: Market opportunity By Geographical Landscape ($ million)
Exhibits134: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits135: Impact of drivers and challenges in 2024 and 2029
Exhibits136: Overview on criticality of inputs and factors of differentiation
Exhibits137: Overview on factors of disruption
Exhibits138: Impact of key risks on business
Exhibits139: Companies covered
Exhibits140: Company ranking index
Exhibits141: Matrix on companies position and classification
Exhibits142: A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
Exhibits143: A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
Exhibits144: A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
Exhibits145: SWOT
Exhibits146: Absorption Pharmaceuticals LLC - Overview
Exhibits147: Absorption Pharmaceuticals LLC - Product / Service
Exhibits148: Absorption Pharmaceuticals LLC - Key offerings
Exhibits149: SWOT
Exhibits150: Alembic Pharmaceuticals Ltd. - Overview
Exhibits151: Alembic Pharmaceuticals Ltd. - Product / Service
Exhibits152: Alembic Pharmaceuticals Ltd. - Key offerings
Exhibits153: SWOT
Exhibits154: Amneal Pharmaceuticals Inc. - Overview
Exhibits155: Amneal Pharmaceuticals Inc. - Business segments
Exhibits156: Amneal Pharmaceuticals Inc. - Key news
Exhibits157: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits158: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits159: SWOT
Exhibits160: Aytu BioPharma Inc. - Overview
Exhibits161: Aytu BioPharma Inc. - Product / Service
Exhibits162: Aytu BioPharma Inc. - Key offerings
Exhibits163: SWOT
Exhibits164: Bayer AG - Overview
Exhibits165: Bayer AG - Business segments
Exhibits166: Bayer AG - Key news
Exhibits167: Bayer AG - Key offerings
Exhibits168: Bayer AG - Segment focus
Exhibits169: SWOT
Exhibits170: Eli Lilly and Co. - Overview
Exhibits171: Eli Lilly and Co. - Product / Service
Exhibits172: Eli Lilly and Co. - Key offerings
Exhibits173: SWOT
Exhibits174: Futura Medical Plc - Overview
Exhibits175: Futura Medical Plc - Product / Service
Exhibits176: Futura Medical Plc - Key offerings
Exhibits177: SWOT
Exhibits178: GlaxoSmithKline Plc - Overview
Exhibits179: GlaxoSmithKline Plc - Business segments
Exhibits180: GlaxoSmithKline Plc - Key news
Exhibits181: GlaxoSmithKline Plc - Key offerings
Exhibits182: GlaxoSmithKline Plc - Segment focus
Exhibits183: SWOT
Exhibits184: Johnson and Johnson Inc. - Overview
Exhibits185: Johnson and Johnson Inc. - Business segments
Exhibits186: Johnson and Johnson Inc. - Key news
Exhibits187: Johnson and Johnson Inc. - Key offerings
Exhibits188: Johnson and Johnson Inc. - Segment focus
Exhibits189: SWOT
Exhibits190: LloydsPharmacy - Overview
Exhibits191: LloydsPharmacy - Product / Service
Exhibits192: LloydsPharmacy - Key offerings
Exhibits193: SWOT
Exhibits194: NeuroHealing Pharmaceuticals Inc. - Overview
Exhibits195: NeuroHealing Pharmaceuticals Inc. - Product / Service
Exhibits196: NeuroHealing Pharmaceuticals Inc. - Key offerings
Exhibits197: SWOT
Exhibits198: Pfizer Inc. - Overview
Exhibits199: Pfizer Inc. - Product / Service
Exhibits200: Pfizer Inc. - Key news
Exhibits201: Pfizer Inc. - Key offerings
Exhibits202: SWOT
Exhibits203: Plethora Solutions Ltd. - Overview
Exhibits204: Plethora Solutions Ltd. - Product / Service
Exhibits205: Plethora Solutions Ltd. - Key offerings
Exhibits206: SWOT
Exhibits207: Veru Inc. - Overview
Exhibits208: Veru Inc. - Business segments
Exhibits209: Veru Inc. - Key news
Exhibits210: Veru Inc. - Key offerings
Exhibits211: Veru Inc. - Segment focus
Exhibits212: SWOT
Exhibits213: Inclusions checklist
Exhibits214: Exclusions checklist
Exhibits215: Currency conversion rates for US$
Exhibits216: Research methodology
Exhibits217: Information sources
Exhibits218: Data validation
Exhibits219: Validation techniques employed for market sizing
Exhibits220: Data synthesis
Exhibits221: 360 degree market analysis
Exhibits222: List of abbreviations

Product Code: IRTNTR70413

Premature Ejaculation Treatment Market 2025-2029

The premature ejaculation treatment market is forecasted to grow by USD 1527.7 mn during 2024-2029, accelerating at a CAGR of 8.6% during the forecast period. The report on the premature ejaculation treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high efficacy of off-label premature ejaculation drugs, increasing demand for topical drug therapies for premature ejaculation treatment, and growing risk factors causing premature ejaculation.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	8%
CAGR	8.6%
Incremental Value	$1527.7 mn

Technavio's premature ejaculation treatment market is segmented as below:

By Route Of Administration

Oral
Topical

By Drug Class

SSRIs
PDE5 inhibitors
Amide anesthetics
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the advent of nanotechnology in premature ejaculation treatment drugs as one of the prime reasons driving the premature ejaculation treatment market growth during the next few years. Also, increasing research and development related to premature ejaculation treatments and emergence of novel devices for premature ejaculation treatments will lead to sizable demand in the market.

The report on the premature ejaculation treatment market covers the following areas:

Premature Ejaculation Treatment Market sizing
Premature Ejaculation Treatment Market forecast
Premature Ejaculation Treatment Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading premature ejaculation treatment market vendors that include A. Menarini Industrie Farmaceutiche Riunite Srl, Absorption Pharmaceuticals LLC, Alembic Pharmaceuticals Ltd., Amneal Pharmaceuticals Inc., Aytu BioPharma Inc., Bayer AG, Eli Lilly and Co., Futura Medical Plc, GlaxoSmithKline Plc, Johnson and Johnson Inc., LloydsPharmacy, NeuroHealing Pharmaceuticals Inc., Niksan Pharmaceutical, Pfizer Inc., Plethora Solutions Ltd., Prinston Pharmaceutical Inc., Ralington Pharma LLP, Sunrise Remedies Pvt. Ltd., Tabuk Pharmaceuticals, and Veru Inc.. Also, the premature ejaculation treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Premature Ejaculation Treatment Market 2019 - 2023
- Historic Market Size - Data Table on Global Premature Ejaculation Treatment Market 2019 - 2023 ($ million)
5.2 Route of Administration segment analysis 2019 - 2023
- Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
5.3 Drug Class segment analysis 2019 - 2023
- Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
5.4 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.5 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on Global Premature Ejaculation Treatment Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Route of Administration

8.1 Market segments
- Chart on Route of Administration - Market share 2024-2029 (%)
- Data Table on Route of Administration - Market share 2024-2029 (%)
8.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
8.3 Oral - Market size and forecast 2024-2029
- Chart on Oral - Market size and forecast 2024-2029 ($ million)
- Data Table on Oral - Market size and forecast 2024-2029 ($ million)
- Chart on Oral - Year-over-year growth 2024-2029 (%)
- Data Table on Oral - Year-over-year growth 2024-2029 (%)
8.4 Topical - Market size and forecast 2024-2029
- Chart on Topical - Market size and forecast 2024-2029 ($ million)
- Data Table on Topical - Market size and forecast 2024-2029 ($ million)
- Chart on Topical - Year-over-year growth 2024-2029 (%)
- Data Table on Topical - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)

9 Market Segmentation by Drug Class

9.1 Market segments
- Chart on Drug Class - Market share 2024-2029 (%)
- Data Table on Drug Class - Market share 2024-2029 (%)
9.2 Comparison by Drug Class
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
9.3 SSRIs - Market size and forecast 2024-2029
- Chart on SSRIs - Market size and forecast 2024-2029 ($ million)
- Data Table on SSRIs - Market size and forecast 2024-2029 ($ million)
- Chart on SSRIs - Year-over-year growth 2024-2029 (%)
- Data Table on SSRIs - Year-over-year growth 2024-2029 (%)
9.4 PDE5 inhibitors - Market size and forecast 2024-2029
- Chart on PDE5 inhibitors - Market size and forecast 2024-2029 ($ million)
- Data Table on PDE5 inhibitors - Market size and forecast 2024-2029 ($ million)
- Chart on PDE5 inhibitors - Year-over-year growth 2024-2029 (%)
- Data Table on PDE5 inhibitors - Year-over-year growth 2024-2029 (%)
9.5 Amide anesthetics - Market size and forecast 2024-2029
- Chart on Amide anesthetics - Market size and forecast 2024-2029 ($ million)
- Data Table on Amide anesthetics - Market size and forecast 2024-2029 ($ million)
- Chart on Amide anesthetics - Year-over-year growth 2024-2029 (%)
- Data Table on Amide anesthetics - Year-over-year growth 2024-2029 (%)
9.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
9.7 Market opportunity by Drug Class
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)

10 Customer Landscape

10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

11.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
11.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
11.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
11.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
11.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
11.7 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
11.8 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
11.9 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
11.10 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
11.11 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
11.12 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
11.13 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
11.14 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
11.15 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
11.16 Saudi Arabia - Market size and forecast 2024-2029
- Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
11.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

12.1 Market drivers
12.2 Market challenges
12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
12.4 Market opportunities/restraints

13 Competitive Landscape

13.1 Overview
13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
- Overview on factors of disruption
13.4 Industry risks
- Impact of key risks on business

14 Competitive Analysis

14.1 Companies profiled
- Companies covered
14.2 Company ranking index
- Company ranking index
14.3 Market positioning of companies
- Matrix on companies position and classification
14.4 A. Menarini Industrie Farmaceutiche Riunite Srl
- A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
- A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
- A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
- SWOT
14.5 Absorption Pharmaceuticals LLC
- Absorption Pharmaceuticals LLC - Overview
- Absorption Pharmaceuticals LLC - Product / Service
- Absorption Pharmaceuticals LLC - Key offerings
- SWOT
14.6 Alembic Pharmaceuticals Ltd.
- Alembic Pharmaceuticals Ltd. - Overview
- Alembic Pharmaceuticals Ltd. - Product / Service
- Alembic Pharmaceuticals Ltd. - Key offerings
- SWOT
14.7 Amneal Pharmaceuticals Inc.
- Amneal Pharmaceuticals Inc. - Overview
- Amneal Pharmaceuticals Inc. - Business segments
- Amneal Pharmaceuticals Inc. - Key news
- Amneal Pharmaceuticals Inc. - Key offerings
- Amneal Pharmaceuticals Inc. - Segment focus
- SWOT
14.8 Aytu BioPharma Inc.
- Aytu BioPharma Inc. - Overview
- Aytu BioPharma Inc. - Product / Service
- Aytu BioPharma Inc. - Key offerings
- SWOT
14.9 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
14.10 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings
- SWOT
14.11 Futura Medical Plc
- Futura Medical Plc - Overview
- Futura Medical Plc - Product / Service
- Futura Medical Plc - Key offerings
- SWOT
14.12 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
14.13 Johnson and Johnson Inc.
- Johnson and Johnson Inc. - Overview
- Johnson and Johnson Inc. - Business segments
- Johnson and Johnson Inc. - Key news
- Johnson and Johnson Inc. - Key offerings
- Johnson and Johnson Inc. - Segment focus
- SWOT
14.14 LloydsPharmacy
- LloydsPharmacy - Overview
- LloydsPharmacy - Product / Service
- LloydsPharmacy - Key offerings
- SWOT
14.15 NeuroHealing Pharmaceuticals Inc.
- NeuroHealing Pharmaceuticals Inc. - Overview
- NeuroHealing Pharmaceuticals Inc. - Product / Service
- NeuroHealing Pharmaceuticals Inc. - Key offerings
- SWOT
14.16 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
14.17 Plethora Solutions Ltd.
- Plethora Solutions Ltd. - Overview
- Plethora Solutions Ltd. - Product / Service
- Plethora Solutions Ltd. - Key offerings
- SWOT
14.18 Veru Inc.
- Veru Inc. - Overview
- Veru Inc. - Business segments
- Veru Inc. - Key news
- Veru Inc. - Key offerings
- Veru Inc. - Segment focus
- SWOT

15 Appendix

15.1 Scope of the report
15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
15.3 Currency conversion rates for US$
- Currency conversion rates for US$
15.4 Research methodology
- Research methodology
15.5 Data procurement
- Information sources
15.6 Data validation
- Data validation
15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
15.8 Data synthesis
- Data synthesis
15.9 360 degree market analysis
- 360 degree market analysis
15.10 List of abbreviations
- List of abbreviations

早漏治療の世界市場 2025～2029年

Global Premature Ejaculation Treatment Market 2025-2029

目次

第1章エグゼクティブサマリー

第2章 Technavio別分析

第3章市場情勢

第4章市場規模

第5章市場規模実績

第6章定性分析

第7章ファイブフォース分析

第8章市場セグメンテーション：投与経路別

第9章市場セグメンテーション薬剤クラス別

第10章顧客情勢

第11章地域別情勢

第12章促進要因・課題・機会・抑制要因

第13章競合情勢

第14章競合分析

第15章付録

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by Route of Administration

9 Market Segmentation by Drug Class

10 Customer Landscape

11 Geographic Landscape

12 Drivers, Challenges, and Opportunity/Restraints

13 Competitive Landscape

14 Competitive Analysis

15 Appendix

早漏治療の世界市場 2025～2029年

Global Premature Ejaculation Treatment Market 2025-2029

目次

第1章 エグゼクティブサマリー

第2章 Technavio別分析

第3章 市場情勢

第4章 市場規模

第5章 市場規模実績

第6章 定性分析

第7章 ファイブフォース分析

第8章 市場セグメンテーション：投与経路別

第9章 市場セグメンテーション薬剤クラス別

第10章 顧客情勢

第11章 地域別情勢

第12章 促進要因・課題・機会・抑制要因

第13章 競合情勢

第14章 競合分析

第15章 付録

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by Route of Administration

9 Market Segmentation by Drug Class

10 Customer Landscape

11 Geographic Landscape

12 Drivers, Challenges, and Opportunity/Restraints

13 Competitive Landscape

14 Competitive Analysis

15 Appendix

第1章エグゼクティブサマリー

第3章市場情勢

第4章市場規模

第5章市場規模実績

第6章定性分析

第7章ファイブフォース分析

第8章市場セグメンテーション：投与経路別

第9章市場セグメンテーション薬剤クラス別

第10章顧客情勢

第11章地域別情勢

第12章促進要因・課題・機会・抑制要因

第13章競合情勢

第14章競合分析

第15章付録